Singapore HSA Pathways: A Guide to Immediate, Expedited & Abridged MedTech Registration

This episode provides a detailed guide to the Singapore Health Sciences Authority (HSA) medical device registration pathways for Class B, C, and D devices. We explore the four main evaluation routes—Full, Abridged, Expedited, and Immediate—and explain how leveraging prior approvals from key international reference agencies like the US FDA and EU Notified Bodies can significantly accelerate your product's entry into the Singaporean market. - What are Singapore's four main evaluation routes for medical devices? - How can a US FDA approval or CE Mark speed up your HSA registration? - Which pathway is required for a novel device with no other market approvals? - What are the specific criteria for the Abridged route for Class B, C, and D devices? - Can your high-risk Class C or D device qualify for an Expedited review? - What are the requirements to get a Class B device registered almost immediately? - Which five global regulatory bodies does Singapore's HSA recognize? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We act as your local representative in over 30 markets, developing efficient regulatory strategies to get your product approved faster. Our advanced AI and data tools streamline the compilation and submission of technical dossiers, helping you identify the best markets for expansion. Whether you are a startup or a multinational, our integrated approach allows a single registration process to access multiple markets, combining global reach with local expertise. Contact us at [email protected] or visit https://pureglobal.com. Explore our FREE AI tools at https://pureglobal.ai.